L. Leonard Lundy is a principal and managing partner of Lundy Law. He concentrates his practice on pharmaceutical litigation and is the chairman of the firm's Mass Tort Department. He has won tens of millions of dollars in the successful prosecution of Fen-phen, Baycol, Zyprexa, Vioxx, Gadolinium, and Hormone Replacement Therapy cases. He presently serves on the plaintiffs' committees for Gadolinium, HRT, Yaz and Reglan mass torts in the Philadelphia Court of Common Pleas. He is admitted to the courts of Pennsylvania, Illinois, and District of Columbia and the Eastern District of Pennsylvania. He is a member of the American, Pennsylvania, and Philadelphia Trial Lawyers Associations. He serves on the boards of numerous philanthropic and civic organizations.